OakChart

Capricor Therapeutics Inc

CAPRHealthcare·Biotechnology·USA·Small·NASD·Nov 11 • 1:12 PM ET

10.54+1.67 (18.83%)
2026-11-11 19:13 CET
Market cap
515.69 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-147.50 USD m
Free cash flow, TTM
-146.29 USD m
EPS diluted, TTM
-2.65
P/E
-
Compare

Price

CAPR against its 20, 50 and 200-day averages
2050200miss
10.0020.0030.0033.2M66.3MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CAPRclose 10.5420-day 7.3850-day 8.08200-day 20.1610.5452w low

73.9% under the 52-week high of 40.37 on 3 Dec 2025. 52-week low 2.96 on 30 Jul 2026. Last 15 sessions, 89.5% high to low

Profile

CAPR
52-week range, 20% of the way up
2.9640.37

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy ("DMD"), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

IndexRUT
Employees231
IPOJun 20, 2002
Beta0.73
ATR, 14d0.89
Rel volume1.54
Short float35.64%
Insider own9.44%
Inst own73.74%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap612.78M
Enterprise Value507.43M
Income-147.50M
Sales0.00M
Book/sh3.61
Cash/sh3.40
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees231
IPOJun 20, 2002

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B2.92
P/C3.10
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio6.77
Current Ratio6.77
Debt/Eq0.44
LT Debt/Eq0.43
Option/ShortYes / Yes

Earnings

EPS (ttm)-2.65
EPS next Y-1.64
EPS next Q-0.37
EPS this Y-4.08%
EPS next Y30.18%
EPS next 5Y47.99%
EPS past 3/5Y-24.12% -20.84%
Sales past 3/5Y- -
EPS Y/Y TTM-49.28%
Sales Y/Y TTM-100.00%
EPS Q/Q-36.52%
Sales Q/Q-
EarningsNov 10 AMC
EPS/Sales Surpr.-66.36% -100.00%

Ownership

Insider Own9.44%
Insider Trans-0.90%
Inst Own73.74%
Inst Trans12.24%
ROA-64.58%
ROE-100.47%
ROIC-49.09%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA2042.90%
SMA5030.52%
SMA200-47.72%
Trades-

Technical

Shs Outstand58.14M
Shs Float52.65M
Short Float35.64%
Short Ratio3.12
Short Interest18.77M
52W High40.37 -73.89%
52W Low2.96 256.08%
Volatility12.11% 9.90%
ATR (14)0.89
RSI (14)66.80
Beta0.73
Rel Volume1.54
Avg Volume6.01M
Volume5,481,125

Performance

Perf Week18.16%
Perf Month53.20%
Perf Quarter150.36%
Perf Half Y-65.25%
Perf YTD-63.48%
Perf Year70.00%
Perf 3Y276.43%
Perf 5Y203.75%
Perf 10Y-61.25%
Recom2.11
Target Price27.00
Prev Close8.87
Price10.54
Change %18.83%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
TodayUpgradeJJones TradingHold → Buy$25+137.2%
Sep 14, 2026UpgradeRB. Riley SecuritiesNeutral → Buy$21+99.2%
Sep 01, 2026UpgradePPiper SandlerNeutral → Overweight$25+137.2%
Aug 25, 2026UpgradeOOppenheimerPerform → Outperform$54+412.3%
Aug 14, 2026UpgradeCCantor FitzgeraldNeutral → Overweight$28+165.7%
Jul 30, 2026DowngradePPiper SandlerOverweight → Neutral$2-81.0%
Jul 30, 2026DowngradeOOppenheimerOutperform → Perform
Jul 30, 2026DowngradeMMaxim GroupBuy → Hold
Jul 30, 2026DowngradeLLadenburg ThalmannBuy → Neutral
Jul 30, 2026DowngradeHH.C. WainwrightBuy → Neutral

Peers

Mkt cap
TickerCompanyMkt cap
SRPTSarepta Therapeutics Inc1.77B
SLDBSolid Biosciences Inc853.27M
WVEWave Life Sciences Inc683.40M
DYNDyne Therapeutics Inc3.41B
EWTXEdgewise Therapeutics Inc5.19B
MESOMesoblast Ltd ADR1.80B
PEPGPepGen Inc365.00M
TNYATenaya Therapeutics Inc87.07M
BCDABioCardia Inc14.23M
LGVNLongeveron Inc9.56M

Insider trading

latest 14 of 35
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Krasney KarenEVP, GENERAL COUNSELJun 25 '26Option Exercise3.1824,10076,63854,647Jun 29 09:30 PM
Krasney KarenEVP, GENERAL COUNSELJun 25 '26Sale30.3824,100732,15830,547Jun 29 09:30 PM
Bergmann AnthonyCHIEF FINANCIAL OFFICERJun 25 '26Option Exercise3.1824,10076,63835,323Jun 29 09:30 PM
Bergmann AnthonyCHIEF FINANCIAL OFFICERJun 25 '26Sale30.3824,100732,15811,223Jun 29 09:30 PM
Krasney KarenEVP, GENERAL COUNSELJun 22 '26Option Exercise3.185001,59031,047Jun 24 08:00 PM
Krasney KarenEVP, GENERAL COUNSELJun 24 '26Option Exercise3.184001,27230,947Jun 24 08:00 PM
Krasney KarenEVP, GENERAL COUNSELJun 22 '26Sale30.0050015,00030,547Jun 24 08:00 PM
Krasney KarenEVP, GENERAL COUNSELJun 24 '26Sale30.0040012,00030,547Jun 24 08:00 PM
Bergmann AnthonyCHIEF FINANCIAL OFFICERJun 22 '26Option Exercise3.185001,59011,723Jun 24 08:00 PM
Bergmann AnthonyCHIEF FINANCIAL OFFICERJun 24 '26Option Exercise3.184001,27211,623Jun 24 08:00 PM
Bergmann AnthonyCHIEF FINANCIAL OFFICERJun 22 '26Sale30.0050015,00011,223Jun 24 08:00 PM
Bergmann AnthonyCHIEF FINANCIAL OFFICERJun 24 '26Sale30.0040012,00011,223Jun 24 08:00 PM
Bergmann AnthonyCHIEF FINANCIAL OFFICERMay 18 '26Option Exercise1.393,0004,17011,223May 19 04:15 PM
Musket David BDirectorMay 19 '26Proposed Sale27.0088,7882,397,256May 19 11:40 AM

Held by

AUM
TickerCompanyAUM
XBIState Street SPDR S&P Biotech ETFAUM: 10.50B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
VHTVanguard Health Care ETFAUM: 21.51B
LABUDirexion Daily S&P Biotech Bull 3X ETFAUM: 583.37M
ITOTiShares Core S&P Total U.S. Stock Market ETFAUM: 95.28B
VTWGVanguard Russell 2000 Growth Index ETFAUM: 1.41B

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-10-0.730-0.439-0.7340.0015.338
2026Q22026-08-13-0.700-0.589-0.7030.000.009
2026Q12026-05-12-0.590-0.523-0.5910.000.007
2025Q42026-03-12-0.620-0.509-0.6180.000.5310
2025Q32025-11-10-0.540-0.547-0.5380.000.609
2025Q22025-08-11-0.570-0.476-0.5670.001.4210
2025Q12025-05-13-0.530-0.317-0.5350.003.166
2024Q42025-03-19-0.160-0.170-0.16011.133.527
2024Q32024-11-13-0.380-0.358-0.3802.264.286
2024Q22024-08-07-0.350-0.356-0.3453.974.585
2024Q12024-05-13-0.310-0.114-0.3124.919.703
2023Q42024-02-29-0.020-0.090-0.02512.0910.603
2023Q32023-11-14-0.250-0.303-0.2486.193.153
2023Q22023-08-07-0.290-0.350-0.2913.923.002
2023Q12023-05-11-0.310-0.320-0.3082.991.002
2022Q42023-03-15-0.310-0.340-0.3070.960.013

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-2.060-1.965-2.0591.010.84
2020FY-0.880-0.880-0.8770.310.25
2021FY-0.870-0.800-0.8670.240.22
2022FY-1.180-1.217-1.1822.551.59
2023FY-0.830-1.040-0.83225.1821.05
2024FY-1.150-1.190-1.14922.2720.97
2025FY-2.260-2.132-2.2600.000.66
2026FY--2.352--52.79
2027FY--1.642--82.54
2028FY--0.318--285.78
2029FY-0.412--416.82
2030FY-1.912--478.67

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1181152.760.00302.77
2026Q4S2026-11-1071044.580.00302.77
2026Q4S2026-11-0671044.580.00302.77
2026Q4S2026-11-0481040.510.00302.77
2026Q4S2026-10-2891051.850.00302.77
2026Q4S2026-10-1291151.850.00302.77
2026Q4S2026-10-0792351.850.00302.77
2026Q4S2026-09-0992451.850.00302.77
2026Q4S2026-08-3192551.850.00302.77
2026Q4S2026-08-1491651.300.00302.77
2026Q4S2026-07-2991551.710.00302.77
2026Q4S2026-07-2892450.740.00280
2026Q4S2026-07-2792351.580.00280
2026Q4S2026-07-2491451.540.00280

Estimate history

EPS, annual0.908-5.165-2.059-0.877-0.867-1.182-0.832-1.149-2.26-2.6456
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.38-0.16-0.535-0.567-0.538-0.618-0.591-0.703-0.734
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual2.6661.6711.0050.310.2452.55125.17822.2700
Period201720182019202020212022202320242025TTM
Sales, quarterly2.26211.1310000000
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual2.6273.1395.22720.57724.18525.24131.14845.58257.37158.139
Period201720182019202020212022202320242025MRQ
Shares, quarterly40.33245.58245.67745.71245.71757.37157.66558.10958.139
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.000.0022.2725.182.550.240.311.011.67
Cost of Goods Sold Incl. D&A2.561.891.431.070.690.25---
Gross Profit-2.56-1.8920.8524.111.86-0.00---
Selling, General and Administrative Excl. Other151.00106.2563.4148.1931.5520.9413.868.5716.87
Research and Development107.5083.5049.1935.8221.8213.578.465.1412.07
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-153.56-108.14-42.56-24.08-29.70-20.94-13.69-7.73-15.36
Interest Expense-3.05-------
Unusual Expense0.000.000.000.000.00-0.32--0.00
Net Income Before Taxes-147.50-105.04-40.47-22.29-29.02-20.02-13.66-7.64-15.19
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-147.50-105.04-40.47-22.29-29.02-20.02-13.66-7.64-15.19
Net Income From Continuing Operations-147.50-105.04-40.47-22.29-29.02-20.02-13.66-7.64-15.19
Net Income-147.50-105.04-40.47-22.29-29.02-20.02-13.66-7.64-15.19
EPS (Recurring)-2.54-2.26-1.15-0.83-1.18-0.88-0.88-2.06-5.17
EPS (Basic, Before Extraordinaries)-2.65-2.26-1.15-0.83-1.18-0.87-0.88-2.06-5.17
EPS (Diluted)-2.65-2.26-1.15-0.83-1.18-0.87-0.88-2.06-5.17
EBITDA-151.00-106.25-41.14-23.01-29.00-20.69-13.55-7.56-15.20
Non-Operating Income (Expense)9.106.152.101.790.680.600.030.090.17
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense17.0413.617.717.394.462.971.950.701.67
Price To Sales Ratio--21.825.2037.14276.24172.154.737.21
Gross Margin--93.6095.7572.77-0.33---
Operating Margin---191.12-95.63-1,163.93-8,549.86-4,412.56-769.52-918.84
Net Margin---181.71-88.52-1,137.37-8,175.86-4,401.94-760.36-908.91
Shares Outstanding58.1457.3745.5831.1525.2424.1920.585.233.14
Market Capitalization515.69515.69627.48150.5897.4370.7670.135.4412.87

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue0.000.000.000.000.000.000.0011.13
Cost of Goods Sold Incl. D&A0.960.560.530.500.490.490.410.38
Gross Profit-0.96-0.56-0.53-0.50-0.49-0.49-0.4110.75
Selling, General and Administrative Excl. Other43.7242.3836.2428.6525.7927.2324.5818.45
Research and Development28.9628.5727.1022.8820.1121.8118.7014.36
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-44.68-42.95-36.77-29.16-26.28-27.72-24.98-7.70
Interest Expense---3.05----
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-42.66-40.73-33.94-30.17-24.57-25.91-24.39-7.12
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-42.66-40.73-33.94-30.17-24.57-25.91-24.39-7.12
Net Income From Continuing Operations-42.66-40.73-33.94-30.17-24.57-25.91-24.39-7.12
Net Income-42.66-40.73-33.94-30.17-24.57-25.91-24.39-7.12
EPS (Recurring)-0.73-0.70-0.59-0.62-0.54-0.57-0.53-0.16
EPS (Basic, Before Extraordinaries)-0.73-0.70-0.59-0.62-0.54-0.57-0.53-0.16
EPS (Diluted)-0.73-0.70-0.59-0.62-0.54-0.57-0.53-0.16
EBITDA-43.72-42.38-36.24-28.65-25.79-27.23-24.58-7.32
Non-Operating Income (Expense)2.032.212.832.031.711.810.590.58
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense6.104.795.920.224.003.655.742.30
Price To Sales Ratio----29.6133.8924.9427.58
Gross Margin-------96.62
Operating Margin--------69.16
Net Margin--------63.94
Shares Outstanding58.1458.1157.6657.3745.7245.7145.6845.58
Market Capitalization515.691,394.521,748.321,570.01329.62453.88433.47627.48

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments318.13151.5239.4941.4234.8932.679.897.5414.87
Short Term Receivables0.0610.3710.370.550.390.000.150.200.34
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets4.751.501.000.921.161.010.510.720.50
Total Current Assets322.94163.3950.8642.8936.4433.6810.548.4715.71
Net Property, Plant & Equipment31.856.877.616.944.620.850.440.570.37
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets---0.000.000.000.010.050.09
Deferred Tax Assets4.001.79-------
Other Assets1.160.220.270.270.280.090.120.150.10
Total Assets359.95172.2758.7350.0941.3334.6211.119.2516.27
Short Term Debt Incl. Current Port. of LT Debt3.620.830.750.680.420.250.000.000.00
Accounts Payable1.653.286.254.923.722.720.901.261.67
Other Current Liabilities30.5616.9124.2717.98-0.00-0.000.000.000.00
Total Current Liabilities35.8421.0331.2723.594.132.970.901.261.67
Long Term Debt14.323.994.865.255.833.453.383.383.38
Provision for Risks Charges0.000.000.000.000.000.000.00-0.00
Deferred Tax Liabilities4.001.79-------
Other Liabilities0.000.000.009.470.000.000.000.000.00
Total Liabilities54.1526.8136.1338.319.966.424.274.635.05
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity305.79145.4622.6011.7931.3728.206.844.6211.23
Total Shareholders Equity305.79145.4622.6011.7931.3728.206.844.6211.23
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity305.79145.4622.6011.7931.3728.206.844.6211.23
Total Liabilities & Stockholders Equity359.95172.2758.7350.0941.3334.6211.119.2516.27
Book Value Per Share5.333.190.730.471.301.371.311.474.27
Tangible Book Value Per Share5.333.190.730.471.301.371.311.454.24
Full-Time Employees231160102744826162240
Price to Book Ratio2.098.15-70.736.182.262.500.982.79-9.29
Return on Assets-39.61-35.04-40.96-63.48-52.73-59.73-75.06-119.0513.89
Return on Equity-46.56-48.16-129.63-134.49-67.23-77.95-133.42-191.7867.32
Return on Invested Capital-32.81-27.08-81.15-170.30-53.83-43.15-74.81-190.0816.65
Quick Ratio9.017.771.631.828.8211.3311.746.759.40
Current Ratio9.017.771.631.828.8211.3311.746.759.40

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-147.50-105.04-40.47-22.29-29.02-20.02-13.66-7.64-15.19
Depreciation2.501.891.431.070.690.250.140.170.16
Other Funds (Non Cash)27.5321.149.837.374.492.791.950.701.73
Funds from Operations-117.48-82.01-29.21-13.84-23.83-16.99-11.56-6.77-13.31
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-2.5212.20-10.78-11.7528.750.181.51-0.06-0.55
Cash from Operating Activities-119.99-69.81-40.00-25.604.92-16.81-10.05-6.82-13.86
Capital Expenditures-26.29-11.72-1.54-2.05-3.36-1.20-0.550.00-0.32
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.120.000.000.000.000.000.000.000.00
Purchase or Sale of Investments-74.23109.20-114.647.16-31.710.005.99-3.004.99
Purchase of Investments-297.32-151.39-208.44-97.44-114.220.00-6.13-6.00-18.01
Sale Or Maturity of Investments223.08260.6093.80104.6082.510.0012.123.0023.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-100.4197.48-116.185.11-35.07-1.205.44-3.004.67
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock252.47248.89152.7725.584.8720.2333.069.186.85
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00-0.000.00
Sale of Common Pref Stock252.47248.89152.7725.584.8720.2333.069.186.85
Proceedsfrom Stock Options237.03237.03152.3225.524.8020.1727.349.176.71
Issuance or Reduction of Debt, Net-6.340.000.000.000.000.000.320.000.00
Change in Long Term Debt-6.340.000.000.000.000.000.320.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.320.000.00
Reduction of Long Term Debt-6.340.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00-0.000.00
Cash from Financing Activities246.13248.89152.7725.584.8720.2333.389.186.85
Net Change in Cash25.73276.56-3.415.09-25.282.2228.77-0.65-2.34
Free Cash Flow-146.29-81.54-41.53-27.641.56-18.01-10.60-6.82-14.18
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow----60.87----
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments197.58237.93278.61318.1398.57122.80
Short Term Receivables0.000.000.000.060.060.06
Inventories0.000.000.000.000.000.00
Other Current Assets4.674.194.484.752.331.27
Total Current Assets202.25242.13283.09322.94100.95124.13
Net Property, Plant & Equipment124.74124.9641.6631.8525.008.93
Total Investments and Advances0.960.000.000.000.000.00
Deferred Tax Assets---4.00--
Other Assets2.421.651.531.160.490.51
Total Assets330.37368.74326.28359.95126.44133.57
Short Term Debt Incl. Current Port. of LT Debt1.521.497.183.623.504.23
Accounts Payable3.053.083.931.652.724.81
Other Current Liabilities25.3328.3922.5330.5621.9319.36
Total Current Liabilities29.9032.9633.6435.8428.1528.40
Long Term Debt90.7189.5613.9414.3214.420.19
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---4.00--
Other Liabilities0.000.000.000.000.000.00
Total Liabilities120.61122.5247.5854.1542.5728.59
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity209.76246.22278.70305.7983.87104.98
Total Shareholders Equity209.76246.22278.70305.7983.87104.98
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity209.76246.22278.70305.7983.87104.98
Total Liabilities & Stockholders Equity330.37368.74326.28359.95126.44133.57
Book Value Per Share3.614.244.835.331.832.30
Tangible Book Value Per Share3.614.244.835.331.832.30
Full-Time Employees---231--
Price to Book Ratio2.094.985.7015.733.143.55
Return on Assets-64.58-51.53-47.74-39.61-74.74-81.44
Return on Equity-100.47-73.70-56.40-46.56-107.79-120.15
Return on Invested Capital-14.20-12.13-11.60-9.43-25.00-24.64
Quick Ratio6.777.358.429.013.594.37
Current Ratio6.777.358.429.013.594.37

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-42.66-40.73-33.94-30.17-24.57-25.91
Depreciation0.900.560.530.500.490.49
Other Funds (Non Cash)7.356.726.197.264.383.63
Funds from Operations-34.40-33.45-27.21-22.41-19.69-21.79
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.291.97-2.04-1.160.011.67
Cash from Operating Activities-35.69-31.49-29.25-23.57-19.69-20.12
Capital Expenditures-4.52-5.90-10.75-5.12-4.01-1.45
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.020.090.000.000.000.00
Purchase or Sale of Investments64.40-42.95-143.8948.2119.9616.00
Purchase of Investments-31.48-75.95-174.89-15.00-58.21-60.00
Sale Or Maturity of Investments95.8733.0031.0063.2178.1876.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities59.90-48.76-154.6443.0915.9514.55
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.092.101.47248.820.010.02
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.092.101.47248.820.010.02
Proceedsfrom Stock Options0.000.000.00237.030.000.00
Issuance or Reduction of Debt, Net0.00-6.340.000.000.000.00
Change in Long Term Debt0.00-6.340.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.00-6.340.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.09-4.241.47248.820.010.02
Net Change in Cash24.30-84.49-182.43268.34-3.73-5.55
Free Cash Flow-40.21-37.39-40.00-28.69-23.70-21.57

Revenue breakdown

Pharmaceutical Preparations2024: 22.27M
United States2024: 22.27M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3035.64%18.8M52.7M5.95M
2026-10-1537.72%19.9M52.7M6.98M
2026-09-3035.76%18.8M52.7M6.79M
2026-09-1537.38%19.7M52.7M6.46M
2026-08-3142.13%22.2M52.7M5.97M
2026-08-1433.74%17.8M52.6M4.20M
2026-07-3130.56%16.0M52.3M2.61M
2026-07-1529.78%15.6M52.3M1.22M
2026-06-3028.18%14.7M52.3M1.17M
2026-06-1522.38%11.7M52.3M1.08M
2026-05-2921.16%11.1M52.3M1.24M
2026-05-1520.87%10.9M52.3M1.31M
2026-04-3020.09%10.5M52.3M1.24M
2026-04-1519.31%10.0M52.0M1.31M
2026-03-3119.14%9.9M51.6M1.38M
2026-03-1314.22%7.3M51.6M1.31M
2026-02-2714.11%6.9M48.8M2.55M
2026-02-1313.58%6.6M48.8M2.69M
2026-01-3011.97%5.9M48.9M2.84M
2026-01-1510.45%5.1M48.9M2.81M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.007.0011.108.950.0001.001.000.993-0.0680.000
call2.006.1010.108.050.0005.002.000.989-0.0710.000
call2.505.509.907.630.0005.001.000.987-0.0710.000
call3.005.009.307.0731.9484.002.000.985-0.0710.000
call3.504.508.506.5524.1871.001.000.983-0.0710.000
call4.004.008.506.1426.1955.001.000.980-0.0700.000
call4.503.508.005.4523.3214.002.000.965-0.1150.001
call5.003.107.504.8017.05410.001.000.961-0.1140.001
call5.502.507.004.3717.4571.001.000.956-0.1110.001
call6.002.605.003.908.11349.0016.000.950-0.1090.001
call6.502.055.603.4010.1226.001.000.917-0.1720.001
call7.003.104.003.006.4341,5161.000.906-0.1660.001
call7.501.005.103.008.14621.000.000.870-0.2100.002
call8.001.604.802.009.4145420.000.851-0.1990.002
call8.501.153.201.737.24032.000.000.772-0.3300.002
call9.001.152.501.725.55915221.000.733-0.3350.003
call9.501.202.502.296.55264.0057.000.687-0.3310.003
call10.001.002.351.606.87310,0852,9280.637-0.4570.003
call10.500.751.901.606.0815033070.619-0.5940.003
call11.000.751.351.304.9225771160.595-0.6320.003
call11.500.152.001.455.5104.000.000.517-0.4850.003
call12.000.101.000.854.9111132980.433-0.3820.003
call12.500.204.801.155.3741.000.000.411-0.4130.003
call13.000.601.050.605.78836913.000.393-0.4410.003
call13.500.054.800.006.1800.000.000.379-0.4650.003
call14.000.201.300.406.55811.0040.000.366-0.4880.003
call14.500.050.700.705.8250.001.000.300-0.4010.003
call15.000.200.800.286.0852026.000.291-0.4140.003
call15.500.004.900.005.9410.000.000.261-0.3830.003
call16.000.004.900.006.2100.000.000.254-0.3950.003
call16.500.004.900.006.4660.000.000.248-0.4060.002
call17.000.001.750.007.1870.000.000.263-0.4640.003
call18.000.050.250.205.4401,9103030.136-0.2360.002
put1.000.000.050.0017.1660.000.00-0.007-0.0630.000
put2.000.000.100.0011.9170.000.00-0.011-0.0660.000
put2.500.004.900.0010.7220.000.00-0.013-0.0700.000
put3.000.000.050.028.94031.000.00-0.017-0.0670.000
put3.500.000.100.057.85768.000.00-0.019-0.0660.000
put4.000.000.050.046.98128313.00-0.022-0.0660.000
put4.500.000.600.057.5950.003.00-0.034-0.1140.001
put5.000.000.200.056.7681,533130-0.039-0.1120.001
put5.500.004.800.057.1423.005.00-0.065-0.1790.001
put6.000.050.100.246.42459.0022.00-0.073-0.1760.001
put6.500.002.300.755.68113.000.00-0.082-0.1710.001
put7.000.050.200.154.980258195-0.094-0.1650.001
put7.500.001.100.404.99757.006.00-0.130-0.2090.002
put8.000.100.300.254.32486.0050.00-0.149-0.1980.002
put8.500.300.700.355.50619332.00-0.228-0.3290.002
put9.000.250.800.705.129116896-0.268-0.3340.003
put9.500.450.900.724.71817.0084.00-0.313-0.3300.003
put10.000.601.501.005.96311.005.00-0.362-0.4560.003
put10.500.102.800.009.4120.000.00-0.381-0.5930.003
put11.000.404.902.7015.6851.000.00-0.407-0.6280.003
put11.500.805.000.0014.3550.000.00-0.485-0.4810.003
put12.001.304.900.0013.1270.000.00-0.565-0.3780.003
put12.501.404.900.0011.8460.000.00-0.589-0.4120.003
put13.001.855.500.0012.6160.000.00-0.607-0.4390.003
put13.502.306.000.0013.0140.000.00-0.621-0.4640.003
put14.002.806.500.0013.3870.000.00-0.634-0.4860.003
put14.503.307.006.1213.6750.000.00-0.747-0.3190.002
put15.003.607.006.5712.4420.000.00-0.709-0.4140.003
put15.503.707.500.0012.7590.000.00-0.717-0.4280.003
put16.003.608.000.0012.9920.000.00-0.771-0.3520.002
put16.504.108.500.0014.0840.000.00-0.752-0.4020.002
put17.005.109.009.0213.6201.000.00-0.737-0.4630.003
put18.006.3010.0010.0014.1323.000.00-0.864-0.2370.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-108-KCurrent report2026-11-10SEC
2026-10-14SCHEDULE 13G/ASEC
2026-09-14SCHEDULE 13GSEC
2026-08-248-KCurrent report2026-08-24SEC
2026-08-19SCHEDULE 13GSEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-138-KCurrent report2026-08-13SEC
2026-08-07SCHEDULE 13GSEC
2026-08-03SCHEDULE 13GSEC
2026-07-308-KCurrent report2026-07-29SEC
2026-07-298-KCurrent report2026-07-29SEC
2026-07-148-KCurrent report2026-07-09SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-25SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-25SEC
2026-06-268-KCurrent report2026-06-26SEC
2026-06-244Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-244Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-088-KCurrent report2026-06-04SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-283Initial statement of beneficial ownership of securities2026-05-25SEC
2026-05-19144/ASEC
2026-05-19144Filing for proposed sale of securities under Rule 144.SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-13SEC
2026-05-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-128-KCurrent report2026-05-12SEC
2026-05-078-KCurrent report2026-05-07SEC
2026-05-044Statement of changes in beneficial ownership of securities2026-05-01SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-06001.52M6
2026-05001.59M2
2026-04001.91M2
2026-03003.35M3
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.7.16%
TANG CAPITAL MANAGEMENT LLC7.08%
MONTANOVA CAPITAL, LLC7.07%
STATE STREET CORP5.87%
VANGUARD CAPITAL MANAGEMENT LLC3.97%
GOLDMAN SACHS GROUP INC2.73%
RA CAPITAL MANAGEMENT, L.P.2.60%
UBS Group AG2.41%
Boxer Capital Management, LLC2.41%
GEODE CAPITAL MANAGEMENT, LLC1.96%

Funds

Fund% owned
State Street(R) SPDR(R) S&P(R) Biotech ETF3.76%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.86%
iShares Russell 2000 ETF2.42%
VANGUARD EXTENDED MARKET INDEX FUND1.02%
Fidelity Small Cap Index Fund1.02%
iShares Russell 2000 Growth ETF0.86%
VANGUARD RUSSELL 2000 INDEX FUND0.53%
Select Pharmaceuticals Portfolio0.40%
Strategic Advisers Fidelity U.S. Total Stock Fund0.33%
VANGUARD HEALTH CARE INDEX FUND0.24%

OakChart. CAPR. Cached 15 minutes.